COVID-19 drug prospects boosted by discovery of short form of coronavirus's 'entry point'
A shadow over the promising inhaled interferon beta COVID-19 therapy has been cleared with the discovery that although it appears to increase levels of ACE2 protein—coronavirus' key entry point into nose and lung cells—it ...
Jan 11, 2021
1
84